MarketInOut Stock Screener Log In | Sign Up

electroCore Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026
electroCore Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization67.8 mln
Float6.05 mln
Earnings Date10/29/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-4.09
Highly reliable

Relative Strength

26 / 100
Underperforming

Pre-Tax Margin

-41%
Deeply loss-making

ROE

525
Extraordinary

Altman Z-Score

-14.65
Deeply distressed

Business Description

Founded in 2005 and based in Rockaway, New Jersey, electroCore develops handheld devices that stimulate the vagus nerve without surgery or implants. Its prescription product, gammaCore, is used to treat migraines, cluster headaches, and related conditions, while its consumer-facing Truvaga line targets general wellness. The company also offers solutions aimed at chronic pain management and human performance enhancement, selling its products across the United States, the United Kingdom, and other international markets.

Key Fundamentals

EPS-1.65
ROE525
RPS4.14
ROIC-157
ROA-83.85
Interest Cover-11.88
EBITDA, mln-12.47
EV / EBITDA-5.68
EV / EBIT-5.10
Revenue, mln36.97
EV / Revenue1.92

Quote Details

Last 7.52
Change -0.59 (-7.27%)
Open 7.76
Volume 63,781
Turnover 479,633
Average Volume 74,055

Financial Ratios

Pre-Tax Profit Margin-41
Current Ratio1.21
Price / Sales1.77

Financial Strength

Altman Z-Score-14.65
Piotroski F-Score 3 / 9
Beneish M-Score-4.09
Short Ratio3.75
Short % of Float4.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.67% 91 / 100   
1 Month -27.13% 13 / 100   
2 Months 24.3% 94 / 100   
6 Months 13.94% 86 / 100   
1 Year 49.21% 91 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog